Li Hong-Dian, Li Ming-Xuan, Zhang Wen-Hua, Zhang Shu-Wen, Gong Yan-Bing
Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
Capital Medical University, Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China.
World J Diabetes. 2023 Sep 15;14(9):1422-1449. doi: 10.4239/wjd.v14.i9.1422.
Diabetic retinopathy (DR) is currently recognized as one of the most serious diabetic microangiopathies and a major cause of adult blindness. Commonly used clinical approaches include etiological control, microvascular improvement, and surgical intervention, but they are ineffective and have many side effects. Oral Chinese medicine (OCM) has been used for thousands of years to treat DR and is still widely used today, but it is unclear which OCM is more effective for DR.
To estimate relative effectiveness and safety profiles for different classes of OCMs for DR, and provide rankings of the available OCMs.
The search time frame was from the creation of the database to January 2023. RevMan 5.3 and Stata 14.0 software were used to perform the systematic review and Network meta-analyses (NMA).
A total of 107 studies and 9710 patients were included, including 4767 cases in the test group and 4973 cases in the control group. Based on previous studies and clinical reports, and combined with the recommendations of Chinese guidelines for the prevention and treatment of DR, 9 OCMs were finally included in this study, namely Compound Xueshuantong Capsules, Qiming Granules, Compound Danshen Dripping Pills, Hexue Mingmu Tablets (HXMM), Qiju Dihuang Pills (QJDH), Shuangdan Mingmu Capsules (SDMM), Danggui Buxue Decoction (DGBX), Xuefu Zhuyu Decoction and Buyang Huanwu Decoction. When these nine OCMs were analyzed in combination with conventional western medicine treatment (CT) compared with CT alone, the NMA results showed that HXMM + CT has better intervention effect on the overall efficacy of DR patients, HXMM + CT has better effect on improving patients' visual acuity, SDMM + CT has better effect on inhibiting vascular endothelial growth factor, DGBX + CT has better effect on reducing fundus hemorrhage area, HXMM + CT has better effect on reducing fasting blood glucose, and QJDH + CT has better effect on reducing glycated hemoglobin. When there are not enough clinical indicators for reference, SDMM + CT or HXMM + CT treatments can be chosen because they are effective for more indicators and demonstrate multidimensional efficacy.
This study provides evidence that combining OCMs with CT leads to better outcomes in all aspects of DR compared to using CT alone. Based on the findings, we highly recommend the use of SDMM or HXMM for the treatment of DR. These two OCMs have demonstrated outstanding efficacy across multiple indicators.
糖尿病视网膜病变(DR)目前被认为是最严重的糖尿病微血管病变之一,也是成人失明的主要原因。常用的临床方法包括病因控制、微血管改善和手术干预,但这些方法效果不佳且有许多副作用。口服中药(OCM)治疗DR已有数千年历史,至今仍被广泛使用,但尚不清楚哪种中药对DR更有效。
评估不同类别的中药治疗DR的相对有效性和安全性,并对现有中药进行排名。
检索时间范围为数据库创建至2023年1月。使用RevMan 5.3和Stata 14.0软件进行系统评价和网状Meta分析(NMA)。
共纳入107项研究和9710例患者,其中试验组4767例,对照组4973例。根据既往研究和临床报道,并结合中国DR防治指南的建议,本研究最终纳入9种中药,即复方血栓通胶囊、芪明颗粒、复方丹参滴丸、和血明目片(HXMM)、杞菊地黄丸(QJDH)、双丹明目胶囊(SDMM)、当归补血汤(DGBX)、血府逐瘀汤和补阳还五汤。当将这9种中药与西医常规治疗(CT)联合分析并与单纯CT比较时,NMA结果显示,HXMM + CT对DR患者的总体疗效有更好的干预效果,HXMM + CT对提高患者视力效果更好,SDMM + CT对抑制血管内皮生长因子效果更好,DGBX + CT对减少眼底出血面积效果更好,HXMM + CT对降低空腹血糖效果更好,QJDH + CT对降低糖化血红蛋白效果更好。当没有足够的临床指标可供参考时,可以选择SDMM + CT或HXMM + CT治疗,因为它们对更多指标有效并显示出多维疗效。
本研究提供的证据表明,与单独使用CT相比,中药与CT联合使用在DR的各个方面都能产生更好的结果。基于这些发现,我们强烈推荐使用SDMM或HXMM治疗DR。这两种中药在多个指标上都显示出了出色的疗效。